Open Data

ES EN

Using machine learning models to guide the design of long - acting injectable drug formulations

Scientists in Canada have developed a way to accelerate the development of new medicines, using artificial intelligence and automation algorithms to speed up the discovery of molecules and drugs needed for sustainable futures within the next few years.

Source: news-medical.net
Published on 2023-01-10

Related news

  • Is machine learning the answer for long - acting injectable drugs ?
  • Three Challenges AI SaaS Startups Must Overcome
  • Infosys launches applied AI cloud powered by NVIDIA DGX A100 systems
  • Open San Diego Offers Aid to Local Governments Using Tech Innovations
  • RARE - X Study Delivers Insights for Diversity , Equality , and Inclusion Programs
  • UNDP data tools to help farmers identify farms resilient to climate change
  • Scientists use machine learning to fast - track drug formulation development
  • UK data strategy 2021 - per ardua , ad nauseam
  • Wisconsin getting $400 million from opioid settlement
  • Children Tumor Foundation Expands into a New Strategic Chapter as Impact Investor in NF Research
  • Fauci : 100 , 000 new Covid deaths in US predictable but preventable | Anthony Fauci
  • Teachers : 1 GB of data daily not enough for online classes
« Virtual Data Engineering Summit to Help Make Data Actionable on January 18th
Using deep sea biology data in the undergrad classroom  »